Market revenue in 2023 | USD 1,799.1 million |
Market revenue in 2030 | USD 3,360.8 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Small molecule |
Fastest growing segment | Large Molecule |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Small Molecule, Large Molecule |
Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Intertek Group PLC, Pace Analytical Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 53.44% in 2023. Horizon Databook has segmented the U.S. bioanalytical testing services market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounts for the highest share in the global bioanalytical testing services market, as many pharmaceutical and biotechnology companies are in this region. Increased R&D investments and a rising need for biopharmaceutical products are key drivers for the market's expansion.
The demand for specific tests, including electrophoresis, electrochemical & titrimetric assays, and immunoassays, has seen a notable upswing due to the development of combination molecules, biosimilars, and other innovative medicines.
Along with this, rapid growth in emerging areas of medicine, such as personalized medicines, orphan drugs, and biosimilars, is expected to propel the bioanalytical testing services market in the U.S. Several key companies providing analytical testing services for pharmaceuticals in the U.S.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into U.S. bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account